$CFBK

Insider Buying: Bradley Ringwald Acquires Shares of CF Bankshares Inc (CFBK)

Bradley Ringwald, President of CF Bankshares Inc (CFBK), recently purchased 1,000 shares of the company, increasing his total ownership to 29,399 shares. The acquisition occurred on December 16, 2025, with shares trading at $24.07, indicating the stock is fairly valued based on its GF Value. This transaction follows a history of insider buys and sells for CF Bankshares, with 6 buys and 5 sells over the past year.

Original reporting
GuruFocus · GuruFocus News
Published Dec 16, 2025, 10:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Dec 16, 2025, 11:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CFBK
Bullish
medium confidence
Mentioned
$CFBK
Relevance
6/10
AlphAI data visualization · based on GuruFocus
Decision brief

The 30-second read

$CFBKBullishMed
01

Why it matters

This insider activity, combined with the stock trading at fair value, suggests a neutral to mildly bullish outlook, but traders should await further confirmation.

02

Market read

The insider activity has limited immediate impact on the broader market but signals internal confidence, which could influence short-term trading decisions.

03

What to watch

Potential upcoming earnings reports or macroeconomic events could overshadow insider activity, and the stock's current fair valuation leaves limited upside.

Relevance 6/10Timing: short-term (1-3 weeks)

Background

Bradley Ringwald, President of CF Bankshares Inc., purchased 1,000 shares at $24.07, indicating confidence in the company's near-term prospects.

Company-level read

Ticker impact

$CFBKBullishMedium confidence
Context

Insider buying activity suggests potential positive sentiment for CF Bankshares Inc.

Expected impact

Moderate upward movement within the next 1-3 weeks, approximately 3-5% increase expected.

Evidence & confidence

Insider buying is generally a bullish indicator, but the limited size of the purchase and current fair valuation suggest cautious optimism rather than a strong buy signal.

Market effects

Potential positive sentiment for regional banks, but limited broader sector impact due to company-specific nature.

Minor positive influence on regional banking stocks in the area.

Negligible

Counterpoint

Insider buying could be motivated by personal reasons or to support a stock that may face upcoming headwinds; thus, it should not be solely relied upon for trading decisions.

Key entities

  • CF Bankshares Inc.

    A regional bank with a focus on community banking services.

  • Bradley Ringwald

    President of CF Bankshares Inc., involved in recent insider purchase.

Related articles

$CFBKMed

CF BANKSHARES INC., PARENT OF CFBANK NA, REPORTS RESULTS FOR THE 2nd QUARTER 2026

CF BANKSHARES INC. (CFBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cfbk-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Parent of CFBank, NA PRESS RELEASE FOR IMMEDIATE RELEASE: July 28, 2026 For Further Information: Timothy T. O'Dell, President & CEO Phone: 614.318.4660 Email: timodell@cfbankmail.com CF BANKSHARES INC., PARENT OF CFBANK NA, R

$GLUEMedAI 8/10

Monte Rosa's MRT-8102 Drives 80%-90% NEK7 Degradation In Phase 1

Monte Rosa Therapeutics (GLUE) reported Phase 1 results showing MRT-8102 achieved 80%-90% NEK7 degradation, reducing biomarkers linked to cardiovascular disease. The treatment was well-tolerated with no serious adverse events. GLUE plans Phase 2 trials in 2026-2027 for coronary artery disease, gout, and hidradenitis suppurativa. GLUE stock is currently down 5.74% at $11.24.

$HDBMed

Top 10@10 | D-Street’s losing streak hits 8 weeks, HDFC Bank and Kotak get new CEOs, Tata Trusts flag concerns

HDFC Bank appointed Anup Bagchi as MD & CEO for a 3-year term, approved by RBI. Kotak Mahindra Bank received RBI approval for Anup Kumar Saha as next MD & CEO, effective January 1, 2027. Tata Trusts raised concerns over a proposed restructuring at Tata Sons. IRDAI aims to improve insurance sector efficiency, while Mahindra reported a 15% increase in September auto sales.